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Enhanced Meningococcal Disease 
Surveillance Report, 2016
Confirmed and Probable Cases Reported to the National 
Notifiable Diseases Surveillance System, 2016*
**Funding for EMDS is provided by CDC through the  
  Epidemiology and Laboratory Capacity for Infectious  
  Diseases (ELC) Cooperative Agreement.
Meningococcal Disease Cases and Incidence by Serogroup and Age











<1 26 (0.67) 4 (0.10) 1 (0.03) 1 (0.03) 1 (0.03) 36 (0.93)
1–4 15 (0.10) 9 (0.06) 3 (0.02) 5 (0.03) 1 (0.01) 33 (0.21)
5–10 5 (0.02) 3 (0.01) 1 (0.00) 0 (0.00) 3 (0.01) 13 (0.05)
11–15 4 (0.02) 2 (0.01) 0 (0.00) 1 (0.00) 1 (0.00) 8 (0.04)
16–23 41 (0.12) 11 (0.03) 2 (0.01) 5 (0.01) 9 (0.03) 72 (0.21)
24–44 19 (0.02) 32 (0.04) 5 (0.01) 8 (0.01) 7 (0.01) 81 (0.09)
45–64 11 (0.01) 26 (0.03) 11 (0.01) 13 (0.02) 2 (0.00) 68 (0.08)
≥65 9 (0.02) 12 (0.02) 11 (0.02) 19 (0.04) 3 (0.01) 61 (0.13)
Total 130 (0.04) 99 (0.03) 34 (0.01) 52 (0.02) 27 (0.01) 372 (0.12)
Includes all confirmed and probable cases; †cases per 100,000 population; 
and ‡includes 5 (1%) cases with other serogroups not listed and 25 (7%) cases with unknown serogroup.
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As part of Enhanced Meningococcal Disease 
Surveillance (EMDS)**, additional data and 
isolates were collected from 45 state and 3 
large jurisdiction health departments. In 
2016, the population under surveillance was 
316,931,626 or 98%    of the U.S. population.  
EMDS focuses on: (1) collecting isolates from 
all cases; (2) collecting complete case 
information, with an emphasis on college 
attendance for cases aged 15–24 years; 
history of sex with men for male cases aged 
≥16 years; and HIV infection status for all 
cases.
CSTE case definition: A confirmed case was 
defined as isolation of Neisseria meningitidis 
or detection of N. meningitidis by PCR from a 
normally sterile body site.
A probable case was defined as detection of 






Cases per 100,000 population
*Delaware, Hawaii, Idaho, South Dakota, Wyoming and the District of Columbia did not participate 
in EMDS; cases reported from these jurisdictions are not included in this report (excluding the map above).
CS283195
Case Fatality
Serogroup No. deaths (CFR†)

















†Case fatality ratio (CFR): deaths per 100 cases with known outcome; 
20 (5%) cases with unknown outcome.
Isolate Submission
288 (78.5%) of 367 confirmed cases had isolates submitted to CDC.
History of sex with men among male 
meningococcal disease cases
Among male cases aged ≥16 years, 57.2% (83/145) had 
information on history of sex with men; of those, 39.8% were 
identified as men who had sex with men (MSM).)
College attendance among meningococcal 
disease cases aged 18-24 years
Among cases aged 18-24 years, 90.9% (60/66) had 
information on college attendance; of those, 53.3% were 
identified as attending college.
Vaccination Status among Cases*
MenACWY** vaccine receipt among college students: 92% 
(19% unknown)
MenACWY vaccine receipt among persons not attending 
college: 44% (43% unknown)
MenB** vaccine receipt among college students: 7% 
(53% unknown)
MenB vaccine receipt among persons not attending college: 0% 
(61% unknown)
*Among those with known vaccine history. **MenACWY = meningococcal conjugate
vaccine, MenB = serogroup B meningococcal vaccine.














college‡ 25 (0.23) 0 (0.00) 0 (0.00) 3 (0.03) 4 (0.04) 32 (0.29)
Not attending 
college‡
9 (0.05) 11 (0.06) 1 (0.01) 2 (0.01) 4 (0.02) 28 (0.15)
†Cases per 100,000 population; and ‡assumes 36.2% of 18–24 year olds attending college1
HIV Infection among Meningococcal 
Disease Cases
Data collected on HIV status will allow CDC to assess the impact 
of the recent Advisory Committee on Immunization Practices 
recommendation for use of MenACWY vaccination in HIV-
infected persons.2
Among all cases, 50.5% (188/372) had information on HIV 
status; of those, 4.3% were identified as HIV-infected.
1College Participation Rates: Percent of 18 to 24 Year Olds Enrolled in College. http://www.higheredinfo.org/dbrowser/index.php?measure=104.
2MacNeil JR, Rubin LG, Patton M, Ortega-Sanchez IR, Martin SW. Recommendations for Use of Meningococcal Conjugate Vaccines in 
 HIV-Infected Persons — Advisory Committee on Immunization Practices, 2016. MMWR Morb Mortal Wkly Rep 2016;65:1189–1194.  
 DOI: http://dx.doi.org/10.15585/mmwr.mm6543a3.
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